beyond reference biologics: biosimilars on the horizon
Published 7 years ago • 482 plays • Length 21:21Download video MP4
Download video MP3
Similar videos
-
2:46
interchangeability 101 - biosimilars & interchangeable biologics
-
14:19
regulatory pathway for biosimilars
-
4:17
biologics vs. biosimilars
-
7:21
biologic drugs and biosimilars
-
11:03
biosimilars in the us and beyond
-
32:37
biologics, biosimilars, and the two-fold u.s. approval framework’s possible impact on prices
-
1:43:14
bi 121 mac shine: systems neurobiology
-
18:00
biosimilars part 1: history and biology
-
4:20
the biosimilar development process
-
11:24
adalimumab biosimilar bi 695501 (cyltezo®; adalimumab-adbm) in rheumatoid arthritis
-
2:47
biologics vs. biosimilars: what’s the difference?
-
10:00
ibd clinical case: the process of switching from a reference biologic to a biosimilar
-
4:12
the basics of biosimilars
-
3:33
biosimilars: manufacturing and inherent variation
-
4:20
the concept of interchangeability
-
2:52
what's health canada saying about biosimilars?
-
16:47
what is needed and what is the role of biosimilars?
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
40:51
biologics and biosimilars interchangeability: a deep dive with industry experts
-
49:37
busting the myths on affordable medicine: how generics and biosimilars drive savings, not costs
-
39:48
optimizing biosimilars for safe and effective management of imids
-
1:59
biosimilars - something new on the health scene